Therapy insight: Management of hepatitis C in patients coinfected with HIV

Research output: Contribution to journalArticle

Abstract

Infection with HCV is common in HIV-infected patients and is an increasingly important public health problem. The medical management of hepatitis C in HIV-infected patients is complicated by immune suppression, potential drug interactions and toxicities, and the relative paucity of health-care providers with expertise in the management of both diseases. Nonetheless, there are now data to support the safety, tolerability and efficacy of hepatitis C treatment with peginterferon plus ribavirin in HIV-infected patients, and the impetus to treat these patients is, therefore, strong. Although the standard of care for the treatment of hepatitis C in HIV-infected patients has been more clearly defined, the delivery of care for hepatitis C remains inconsistent in many settings. The development and implementation of single-center multidisciplinary programs that combine the expertise of HIV specialists, hepatologists, gastroenterologists, psychiatrists, and addiction specialists, are needed to improve hepatitis C treatment outcomes in HIV-infected patients. This review considers the management of HCV infection in HIV-infected patients.

Original languageEnglish (US)
Pages (from-to)223-231
Number of pages9
JournalNature Clinical Practice Gastroenterology and Hepatology
Volume2
Issue number5
DOIs
StatePublished - May 2005

Fingerprint

Hepatitis C
HIV
Therapeutics
Ribavirin
Standard of Care
Disease Management
Drug-Related Side Effects and Adverse Reactions
Drug Interactions
Health Personnel
HIV Infections
Psychiatry
Public Health
Safety
Infection

Keywords

  • HCV
  • HIV
  • Interferon
  • Ribavirin
  • Treatment

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Therapy insight : Management of hepatitis C in patients coinfected with HIV. / Sulkowski, Mark.

In: Nature Clinical Practice Gastroenterology and Hepatology, Vol. 2, No. 5, 05.2005, p. 223-231.

Research output: Contribution to journalArticle

@article{0990d22d52164f4ba2a897a98f461c49,
title = "Therapy insight: Management of hepatitis C in patients coinfected with HIV",
abstract = "Infection with HCV is common in HIV-infected patients and is an increasingly important public health problem. The medical management of hepatitis C in HIV-infected patients is complicated by immune suppression, potential drug interactions and toxicities, and the relative paucity of health-care providers with expertise in the management of both diseases. Nonetheless, there are now data to support the safety, tolerability and efficacy of hepatitis C treatment with peginterferon plus ribavirin in HIV-infected patients, and the impetus to treat these patients is, therefore, strong. Although the standard of care for the treatment of hepatitis C in HIV-infected patients has been more clearly defined, the delivery of care for hepatitis C remains inconsistent in many settings. The development and implementation of single-center multidisciplinary programs that combine the expertise of HIV specialists, hepatologists, gastroenterologists, psychiatrists, and addiction specialists, are needed to improve hepatitis C treatment outcomes in HIV-infected patients. This review considers the management of HCV infection in HIV-infected patients.",
keywords = "HCV, HIV, Interferon, Ribavirin, Treatment",
author = "Mark Sulkowski",
year = "2005",
month = "5",
doi = "10.1038/ncpgasthep0170",
language = "English (US)",
volume = "2",
pages = "223--231",
journal = "Nature Reviews Gastroenterology and Hepatology",
issn = "1759-5045",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Therapy insight

T2 - Management of hepatitis C in patients coinfected with HIV

AU - Sulkowski, Mark

PY - 2005/5

Y1 - 2005/5

N2 - Infection with HCV is common in HIV-infected patients and is an increasingly important public health problem. The medical management of hepatitis C in HIV-infected patients is complicated by immune suppression, potential drug interactions and toxicities, and the relative paucity of health-care providers with expertise in the management of both diseases. Nonetheless, there are now data to support the safety, tolerability and efficacy of hepatitis C treatment with peginterferon plus ribavirin in HIV-infected patients, and the impetus to treat these patients is, therefore, strong. Although the standard of care for the treatment of hepatitis C in HIV-infected patients has been more clearly defined, the delivery of care for hepatitis C remains inconsistent in many settings. The development and implementation of single-center multidisciplinary programs that combine the expertise of HIV specialists, hepatologists, gastroenterologists, psychiatrists, and addiction specialists, are needed to improve hepatitis C treatment outcomes in HIV-infected patients. This review considers the management of HCV infection in HIV-infected patients.

AB - Infection with HCV is common in HIV-infected patients and is an increasingly important public health problem. The medical management of hepatitis C in HIV-infected patients is complicated by immune suppression, potential drug interactions and toxicities, and the relative paucity of health-care providers with expertise in the management of both diseases. Nonetheless, there are now data to support the safety, tolerability and efficacy of hepatitis C treatment with peginterferon plus ribavirin in HIV-infected patients, and the impetus to treat these patients is, therefore, strong. Although the standard of care for the treatment of hepatitis C in HIV-infected patients has been more clearly defined, the delivery of care for hepatitis C remains inconsistent in many settings. The development and implementation of single-center multidisciplinary programs that combine the expertise of HIV specialists, hepatologists, gastroenterologists, psychiatrists, and addiction specialists, are needed to improve hepatitis C treatment outcomes in HIV-infected patients. This review considers the management of HCV infection in HIV-infected patients.

KW - HCV

KW - HIV

KW - Interferon

KW - Ribavirin

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=20444498277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444498277&partnerID=8YFLogxK

U2 - 10.1038/ncpgasthep0170

DO - 10.1038/ncpgasthep0170

M3 - Article

C2 - 16265205

AN - SCOPUS:20444498277

VL - 2

SP - 223

EP - 231

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

SN - 1759-5045

IS - 5

ER -